VRDN icon

Viridian Therapeutics

105 hedge funds and large institutions have $778M invested in Viridian Therapeutics in 2022 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 51 increasing their positions, 14 reducing their positions, and 10 closing their positions.

Holders
105
Holders Change
+21
Holders Change %
+25%
% of All Funds
1.82%
Holding in Top 10
10
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+66.67%
% of All Funds
0.17%
New
31
Increased
51
Reduced
14
Closed
10
Calls
$3.62M
Puts
$652K
Net Calls
+$2.97M
Net Calls Change
-$2.69M
Name Holding Trade Value Shares
Change
Shares
Change %
Wells Fargo
101
Wells Fargo
California
$16K +$3.84K +194 +32%
Fidelity Investments
102
Fidelity Investments
Massachusetts
$9K +$7.6K +374 +542%
Royal Bank of Canada
103
Royal Bank of Canada
Ontario, Canada
$7K +$3.84K +177 +121%
CHA
104
Carmichael Hill & Associates
Maryland
$1K
FLSM
105
Frazier Life Sciences Management
California
-$11.3M -980,302 Closed
ABG
106
Ally Bridge Group
New York
-$5.74M -496,012 Closed
Franklin Resources
107
Franklin Resources
California
-$2.89M -250,000 Closed
BM
108
Bridger Management
New York
-$767K -66,300 Closed
AllianceBernstein
109
AllianceBernstein
Tennessee
-$584K -50,479 Closed
AAA
110
Affinity Asset Advisors
New York
-$239K -20,660 Closed
CM
111
Caption Management
Oklahoma
-$206K -17,777 Closed
AI
112
Atom Investors
Texas
-$124K -10,699 Closed
PP
113
PDT Partners
New York
-$117K -10,114 Closed
LC
114
Lindbrook Capital
California
-$12K -1,006 Closed